Brain Volumetric Alterations in Preclinical HIV-Associated Neurocognitive Disorder Using Automatic Brain Quantification and Segmentation Tool

被引:10
|
作者
Li, Ruili [1 ,2 ]
Qi, Yu [2 ]
Shi, Lin [3 ,4 ]
Wang, Wei [2 ]
Zhang, Aidong [2 ]
Luo, Yishan [3 ]
Kung, Wing Kit [3 ]
Jiao, Zengxin [2 ]
Liu, Guangxue [5 ]
Li, Hongjun [2 ]
Zhang, Longjiang [1 ]
机构
[1] Nanjing Univ, Jinling Hosp, Dept Med Imaging, Med Sch, Nanjing, Peoples R China
[2] Capital Med Univ, Beijing Youan Hosp, Dept Radiol, Beijing, Peoples R China
[3] BrainNow Res Inst, Shenzhen, Peoples R China
[4] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Peoples R China
[5] Peking Univ, Sch Pharmaceut Sci, Dept Nat Med, Hlth Sci Ctr, Beijing, Peoples R China
基金
北京市自然科学基金; 中国国家自然科学基金;
关键词
HIV; neurocognitive disorder; brain volumetric alterations; MR imaging; T-1-weighted imaging; COMBINATION ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS-INFECTION; PLUS INDIVIDUALS; RESTING-STATE; PERFORMANCE; ACTIVATION;
D O I
10.3389/fnins.2021.713760
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Purpose: This study aimed to determine if people living with HIV (PLWH) in preclinical human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND), with no clinical symptoms and without decreased daily functioning, suffer from brain volumetric alterations and its patterns. Method: Fifty-nine male PLWH at the HAND preclinical stage were evaluated, including 19 subjects with asymptomatic neurocognitive impairment (ANI), 17 subjects with cognitive abnormality that does not reach ANI (Not reach ANI), and 23 subjects with cognitive integrity. Moreover, 23 healthy volunteers were set as the seronegative normal controls (NCs). These individuals underwent sagittal three-dimensional T-1-weighted imaging (3D T1WI). Quantified data and volumetric measures of brain structures were automatically segmented and extracted using AccuBrain(R). In addition, the multiple linear regression analysis was performed to analyze the relationship of volumes of brain structures and clinical variables in preclinical HAND, and the correlations of the brain volume parameters with different cognitive function states were assessed by Pearson's correlation analysis. Results: The significant difference was shown in the relative volumes of the ventricular system, bilateral lateral ventricle, thalamus, caudate, and left parietal lobe gray matter between the preclinical HAND and NCs. Furthermore, the relative volumes of the bilateral thalamus in preclinical HAND were negatively correlated with attention/working memory (left: r = -0.271, p = 0.042; right: r = -0.273, p = 0.040). Higher age was associated with increased relative volumes of the bilateral lateral ventricle and ventricular system and reduced relative volumes of the left thalamus and parietal lobe gray matter. The lower CD4(+)/CD8(+) ratio was associated with increased relative volumes of the left lateral ventricle and ventricular system. Longer disease course was associated with increased relative volumes of the bilateral thalamus. No significant difference was found among preclinical HAND subgroups in all indices, and the difference between the individual groups (Not reach ANI and Cognitive integrity groups) and NCs was also insignificant. However, there was a significant difference between ANI and NCs in the relative volumes of the bilateral caudate and lateral ventricle. Conclusion: Male PLWH at the HAND preclinical stage suffer from brain volumetric alterations. AccuBrain(R) provides potential value in evaluating HIV-related neurocognitive dysfunction.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Triggering receptor expressed on myeloid cells 2 levels are altered in the brain during HIV-associated neurocognitive disorders
    Fields, J. A.
    Spencer, B.
    Martin, E.
    Alexeeva, A.
    Gough, S.
    Flores, I
    Achim, C.
    Desplats, P.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S54 - S55
  • [42] Excess Soluble CD40L Contributes to Blood-Brain Barrier Permeability in a Mouse Model of HIV-associated Neurocognitive Disorder (Hand).
    Davidson, D. C.
    Hirschman, M. P.
    Sun, A.
    Kasischke, K. A.
    Schifitto, G.
    Maggirwar, S. B.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 : S14 - S14
  • [43] Serological ATP plays a role in HIV-associated neurocognitive disorder by promoting transcellular trans-endothelial migration through the blood-brain barrier
    Hernandez, Cristian
    Eugenin, Eliseo
    JOURNAL OF NEUROVIROLOGY, 2023, 29 : S13 - S14
  • [44] Excess Soluble CD40L Contributes to Blood-Brain Barrier Permeability in a Mouse Model of HIV-associated Neurocognitive Disorder (HAND)
    Davidson, D. C.
    Hirschman, M. P.
    Sun, A.
    Kasischke, K. A.
    Schifitto, G.
    Maggirwar, S. B.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 : S35 - S36
  • [45] Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use
    Kamminga, Jody
    Lal, Luxshimi
    Wright, Edwina J.
    Bloch, Mark
    Brew, Bruce J.
    Cysique, Lucette A.
    CURRENT HIV/AIDS REPORTS, 2017, 14 (03) : 83 - 92
  • [46] Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use
    Jody Kamminga
    Luxshimi Lal
    Edwina J. Wright
    Mark Bloch
    Bruce J. Brew
    Lucette A. Cysique
    Current HIV/AIDS Reports, 2017, 14 : 83 - 92
  • [47] HIV-ASSOCIATED NEUROCOGNITIVE DISORDER: AN INVESTIGATION USING STRUCTURAL NEUROIMAGING IN A C-ART TREATED TANZANIAN COHORT
    McDonald, Lucy
    Koipapi, Sengua
    Howlett, William
    Dekker, Marieke
    Urasa, Sarah
    Kalaria, Rajesh
    Walker, Richard
    Firbank, Michael
    Paddick, Stella-Maria
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 (08):
  • [48] Microbial molecule ingress promotes neuroinflammation and brain CCR5 expression in persons with HIV-associated neurocognitive disorders
    Branton, William G.
    Fernandes, Jason P.
    Mohammadzadeh, Nazanin
    Doan, Mathew A. L.
    Laman, Jon D.
    Gelman, Benjamin B.
    Fagrouch, Zahra
    Kondova, Ivanela
    Mooij, Petra
    Koopman, Gerrit
    Power, Christopher
    BRAIN BEHAVIOR AND IMMUNITY, 2023, 107 : 110 - 123
  • [49] A mouse model of HIV-associated neurocognitive disorders: a brain-behavior approach to discover disease mechanisms and novel treatments
    Tyor, William R.
    Bimonte-Nelson, Heather
    JOURNAL OF NEUROVIROLOGY, 2018, 24 (02) : 180 - 184
  • [50] Elevation of brain ADC (apparent diffusion coefficient) in HIV-associated neurocognitive disorders and evolution after treatment: A pilot study
    Law-Ye, Bruno
    de Truchis, Pierre
    Peyrassou, David
    Force, Gilles
    Carlier, Robert-Yves
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 442